ATE201995T1 - Verfahren zur prävention und behandlung der rindermastitis - Google Patents

Verfahren zur prävention und behandlung der rindermastitis

Info

Publication number
ATE201995T1
ATE201995T1 AT94925425T AT94925425T ATE201995T1 AT E201995 T1 ATE201995 T1 AT E201995T1 AT 94925425 T AT94925425 T AT 94925425T AT 94925425 T AT94925425 T AT 94925425T AT E201995 T1 ATE201995 T1 AT E201995T1
Authority
AT
Austria
Prior art keywords
pct
infection
gallidermin
epidermin
sec
Prior art date
Application number
AT94925425T
Other languages
English (en)
Inventor
John Edmondson Peel
Bruno Suri
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE201995T1 publication Critical patent/ATE201995T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94925425T 1993-08-20 1994-08-03 Verfahren zur prävention und behandlung der rindermastitis ATE201995T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810588 1993-08-20
PCT/EP1994/002567 WO1995005844A1 (en) 1993-08-20 1994-08-03 Method for the prevention and treatment of bovine mastitis

Publications (1)

Publication Number Publication Date
ATE201995T1 true ATE201995T1 (de) 2001-06-15

Family

ID=8215016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94925425T ATE201995T1 (de) 1993-08-20 1994-08-03 Verfahren zur prävention und behandlung der rindermastitis

Country Status (13)

Country Link
US (1) US5710124A (de)
EP (1) EP0789581B1 (de)
JP (1) JP3670280B2 (de)
AT (1) ATE201995T1 (de)
AU (1) AU689494B2 (de)
CA (1) CA2169847C (de)
DE (1) DE69427492T2 (de)
DK (1) DK0789581T3 (de)
ES (1) ES2157985T3 (de)
GR (1) GR3036573T3 (de)
NZ (1) NZ271650A (de)
PT (1) PT789581E (de)
WO (1) WO1995005844A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE215378T1 (de) 1996-06-20 2002-04-15 Novartis Ag Micrococcin antibiotika zur prävention und therapie der mastitis
US6406907B1 (en) 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
WO2005107787A1 (en) * 2004-05-06 2005-11-17 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
EP1896603B1 (de) * 2005-06-29 2013-11-06 Biotech Concepts GmbH Biosynthetisches verfahren zur herstellung von gallidermin
EP1940437B1 (de) * 2005-07-28 2013-09-04 Biosynexus Incorporated Zusammensetzungen und verfahren zur behandlung von bakterien
US7576054B2 (en) * 2005-10-11 2009-08-18 Biosynexus Incorporated Compositions and methods for treating bacteria
EP2810695A1 (de) * 2013-06-06 2014-12-10 Ceva Sante Animale Zusammensetzungen und Verfahren zur Bekämpfung von Infektionen bei nichtmenschlichen Säugern unter Verwendung von Akute-Phase-Proteinen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) * 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
GB8811760D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
AU623864B2 (en) * 1988-08-29 1992-05-28 Applied Microbiology, Inc Method of treating mastitis and other staphylococcal infections
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
DE3938140A1 (de) * 1989-11-16 1991-08-08 Beiersdorf Ag Desodorierende kosmetische mittel
IL104364A (en) * 1992-01-17 1997-09-30 Applied Microbiology Pharmaceutical compositions containing bacteriocins

Also Published As

Publication number Publication date
NZ271650A (en) 1997-11-24
JPH09502171A (ja) 1997-03-04
AU689494B2 (en) 1998-04-02
CA2169847A1 (en) 1995-03-02
US5710124A (en) 1998-01-20
JP3670280B2 (ja) 2005-07-13
EP0789581B1 (de) 2001-06-13
GR3036573T3 (en) 2001-12-31
WO1995005844A1 (en) 1995-03-02
DK0789581T3 (da) 2001-09-17
DE69427492T2 (de) 2002-04-18
DE69427492D1 (de) 2001-07-19
AU7534694A (en) 1995-03-21
ES2157985T3 (es) 2001-09-01
CA2169847C (en) 2006-02-14
PT789581E (pt) 2001-11-30
EP0789581A1 (de) 1997-08-20

Similar Documents

Publication Publication Date Title
PT934075E (pt) Metodo para a prevencao e tratamento da mastite
Eberhart Management of dry cows to reduce mastitis
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
DE69430823D1 (de) Verfahren zur behandlung von gram-negativen bakterien infektion durch verabreichung von bakterientötendem/durchlässigkeiterhöhendem (bpi) proteinprodukt und antibiotikum
ATE109624T1 (de) Bakteriocine enthaltende zusammensetzungen zur verwendung als verbesserte breitspektrum- bakterizide und verfahren zur verhütung und behandlung von mikrobiellen infektionen.
MY113059A (en) Controlled-release dosage forms of azithromycin
ATE174510T1 (de) Präparat zur behandlung und verhütung von bakteriellen infektionen,das chlordioxyd enthalt
ATE201995T1 (de) Verfahren zur prävention und behandlung der rindermastitis
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
DK0497956T3 (da) Præparater med reguleret frigivelse
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
DE69005062D1 (de) Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
Silver et al. The effect of interleukin 1α on survival in a murine model of burn wound sepsis
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
ATE167628T1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
ATE279939T1 (de) Phytase zur vorbeugung oder behandlung von mastitis
DE60222298D1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem beta-lactam-antibiotikum
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
GB9201013D0 (en) Vaccines
DE60228324D1 (de) Verfahren zur behandlung von bakteriellen infektionen mit gemifloxacin oder einem seiner salze und einem antibakteriellen carbapenem-mittel
DE69740072D1 (de) Menschliches wachstumshormon zur behandlung von anorexia nervosa
胡宝生 et al. CLINICAL OBSERVATION ON AURICULAR POINT TREATMENT FOR 144 CASES OF BILIARY COLIC
MY104932A (en) Immunomodulatory azaspiranes

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner